Tagged: olo

OurCrowd Portfolio Company Supports Coronavirus Quarantine Needs

Sight Diagnostics, an OurCrowd portfolio company, is helping to lead the response to the Coronavirus pandemic. Sight’s OLO, a compact blood analyzer that can provide rapid, lab-grade CBC [complete blood count] results, has been installed in Sheba Tel Hashomer’s (Israel’s largest hospital that is supported… Read More

Where Theranos Failed, OurCrowd Portfolio Company Sight Diagnostics Succeeds as FDA Clears Finger-Prick Blood Test

We all know the story of Elizabeth Holmes and the demise of Theranos, a company that claimed to have created a device that could provide fast and efficient blood tests. Theranos ended being a company based on hubris, imagination, and vapor. It eventually collapsed being… Read More

OurCrowd Joins $27.8 Million Series C of Sight Diagnostic Creator of Point-of-Care Blood Diagnostics System

OurCrowd has joined in the Series C funding of Medtech firm Sight Diagnostics. The company is creating a lab-grade point-of-care blood diagnostics system “OLO.” This system is designed to provide patients with lab-grade blood testing results in minutes rather than days by combining AI with… Read More

Send this to a friend